Association between thoracic spinal cord gray matter atrophy and disability in multiple sclerosis

JAMA Neurology

Volumn 72, Issue 8, 2015, Pages 897-904

  Schlaeger, Regina ^a,b   Papinutto, Nico ^a   Zhu, Alyssa H ^a   Lobach, Iryna V ^a,c   Bevan, Carolyn J ^a   Bucci, Monica ^a   Castellano, Antonella ^a   Gelfand, Jeffrey M ^a   Graves, Jennifer S ^a   Green, Ari J ^a   Jordan, Kesshi M ^a,c   Keshavan, Anisha ^a,c   Panara, Valentina ^a   Stern, William A ^a   Von Büdingen, H Christian ^a   Waubant, Emmanuelle ^a   Goodin, Douglas S ^a   Cree, Bruce A C ^a   Hauser, Stephen L ^a   Henry, Roland G ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN SIZE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; EXPANDED DISABILITY STATUS SCALE; FEMALE; GRAY MATTER; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; PRIORITY JOURNAL; SPINAL CORD ATROPHY; THORACIC SPINAL CORD; UNIVERSITY HOSPITAL; WHITE MATTER; ATROPHY; DISABILITY; DISEASE COURSE; MIDDLE AGED; PATHOLOGY; SPINAL CORD; VERTEBRA;

ADULT; AGED; ATROPHY; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; DISEASE PROGRESSION; FEMALE; GRAY MATTER; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; SPINAL CORD; THORACIC VERTEBRAE;

EID: 84938912066     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2015.0993     Document Type: Article

References (46)

1. Kidd D, Thorpe JW, Thompson AJ, et al. Spinal cord MRI using multi-array coils and fast spin echo, II: findings in multiple sclerosis. Neurology. 1993;43 (12):2632-2637.
2. Lin X, Tench CR, Evangelou N, Jaspan T, Constantinescu CS. Measurement of spinal cord atrophy in multiple sclerosis. J Neuroimaging. 2004;14(3)(suppl):20S-26S.
3. Bakshi R, Dandamudi VS, Neema M, De C, Bermel RA. Measurement of brain and spinal cord atrophy by magnetic resonance imaging as a tool to monitor multiple sclerosis. J Neuroimaging. 2005; 15(4)(suppl):30S-45S.
4. Lin X, Tench CR, Turner B, Blumhardt LD, Constantinescu CS. Spinal cord atrophy and disability in multiple sclerosis over four years: application of a reproducible automated technique in monitoring disease progression in a cohort of the interferon beta-1a (Rebif) treatment trial. J Neurol Neurosurg Psychiatry. 2003;74(8):1090-1094.
5. Kalkers NF, Barkhof F, Bergers E, van Schijndel R, Polman CH. The effect of the neuroprotective agent riluzole on MRI parameters in primary progressive multiple sclerosis: a pilot study. Mult Scler. 2002;8 (6):532-533.
6. Leary SM, Miller DH, Stevenson VL, Brex PA, Chard DT, Thompson AJ. Interferon beta-1a in primary progressive MS: an exploratory, randomized, controlled trial. Neurology. 2003;60 (1):44-51.
7. Montalban X, Sastre-Garriga J, Tintoré M, et al. A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis. Mult Scler. 2009;15(10):1195-1205.
8. Losseff NA, Webb SL, O'Riordan JI, et al. Spinal cord atrophy and disability in multiple sclerosis: a new reproducible and sensitive MRI method with potential to monitor disease progression. Brain. 1996;119(pt 3):701-708.
9. Bieniek M, Altmann DR, Davies GR, et al. Cord atrophy separates early primary progressive and relapsing remitting multiple sclerosis. J Neurol Neurosurg Psychiatry. 2006;77(9):1036-1039.
10. Rocca MA, Horsfield MA, Sala S, et al. A multicenter assessment of cervical cord atrophy among MS clinical phenotypes. Neurology. 2011;76 (24):2096-2102.
11. Bonati U, Fisniku LK, Altmann DR, et al. Cervical cord and brain grey matter atrophy independently associate with long-term MS disability. J Neurol Neurosurg Psychiatry. 2011;82(4):471-472.
12. Kearney H, Rocca MA, Valsasina P, et al. Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease duration. Mult Scler. 2014;20(1):72-80.
13. Ganter P, Prince C, Esiri MM. Spinal cord axonal loss in multiple sclerosis: a post-mortem study. Neuropathol Appl Neurobiol. 1999;25(6):459-467.
14. Bjartmar C, Kidd G, Mörk S, Rudick R, Trapp BD. Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients. Ann Neurol. 2000;48(6):893-901.
15. DeLuca GC, Ebers GC, Esiri MM. Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts. Brain. 2004;127(pt 5):1009-1018.
16. Gilmore CP, DeLuca GC, Bö L, et al. Spinal cord neuronal pathology in multiple sclerosis. Brain Pathol. 2009;19(4):642-649.
17. Bot JC, Blezer EL, Kamphorst W, et al. The spinal cord in multiple sclerosis: relationship of high-spatial-resolution quantitative MR imaging findings to histopathologic results. Radiology. 2004;233(2):531-540.
18. Gilmore CP, DeLuca GC, Bö L, et al. Spinal cord atrophy in multiple sclerosis caused by white matter volume loss. Arch Neurol. 2005;62(12): 1859-1862.
19. Grinberg LT, Amaro E Jr, Teipel S, et al; Brazilian Aging Brain Study Group. Assessment of factors that confound MRI and neuropathological correlation of human postmortem brain tissue. Cell Tissue Bank. 2008;9(3):195-203.
20. Kretschmann HJ, Tafesse U, Herrmann A. Different volume changes of cerebral cortex and white matter during histological preparation. Microsc Acta. 1982;86(1):13-24.
21. Dietrich O, Reiser MF, Schoenberg SO. Artifacts in 3-T MRI: physical background and reduction strategies. Eur J Radiol. 2008;65(1):29-35.
22. Stroman PW, Wheeler-Kingshott C, Bacon M, et al. The current state-of-the-art of spinal cord imaging: methods. Neuroimage. 2014;84:1070-1081.
23. Kellman P, Arai AE, McVeigh ER, Aletras AH. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Magn Reson Med. 2002;47(2): 372-383.
24. Huber AM, Schoenberg SO, Hayes C, et al. Phase-sensitive inversion-recovery MR imaging in the detection of myocardial infarction. Radiology. 2005;237(3):854-860.
25. Kearney H, Miszkiel KA, Yiannakas MC, Ciccarelli O, Miller DH. A pilot MRI study of white and grey matter involvement by multiple sclerosis spinal cord lesions. Mult Scler Relat Disord. 2013;2 (2):103-108.
26. Kearney H, Yiannakas MC, Abdel-Aziz K, et al. Improved MRI quantification of spinal cord atrophy in multiple sclerosis. J Magn Reson Imaging. 2014; 39(3):617-623.
27. Papinutto N, Schlaeger R, Panara V, et al. 2D phase-sensitive inversion recovery imaging to measure in vivo spinal cord gray and white matter areas in clinically feasible acquisition times [published online December 8, 2014]. J Magn Reson Imaging. doi:10.1002/jmri.24819.
28. Schlaeger R, Papinutto N, Panara V, et al. Spinal cord gray matter atrophy correlates with multiple sclerosis disability. Ann Neurol. 2014;76(4):568-580.
29. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292-302.
30. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33(11):1444-1452.
31. Kappos L, Lechner-Scott J, Wu S. Neurostatus.net: independent internet platform for training and certification of physicians participating in projects that use a standardised, quantified neurological examination and assessment of Kurtzke's Functional Systems and Expanded Disability Status Scale in Multiple Sclerosis. http://www.neurostatus.net. 2009 (version 9/2008). Accessed July 1, 2013.
32. Fischer JS, Rudick RA, Cutter GR, Reingold SC; National MS Society Clinical Outcomes Assessment Task Force. The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. Mult Scler. 1999;5(4):244-250.
33. Horsfield MA, Sala S, Neema M, et al. Rapid semi-automatic segmentation of the spinal cord from magnetic resonance images: application in multiple sclerosis. Neuroimage. 2010;50(2):446-455.
34. Groemping U. Relative importance for linear regression in R: the Package Relaimpo. J Stat Softw. 2006;17.
35. Genizi A. Decomposition of R2 in multiple regression with correlated regressors. Stat Sin. 1993;3:407-420.
36. Lublin FD, Reingold SC, Cohen JA, et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology. 2014;83(3):278-286.
37. Liu W, Nair G, Vuolo L, et al. In vivo imaging of spinal cord atrophy in neuroinflammatory diseases. Ann Neurol. 2014;76(3):370-378.
38. Klein JP, Arora A, Neema M, et al. A 3T MR imaging investigation of the topography of whole spinal cord atrophy in multiple sclerosis. AJNR Am J Neuroradiol. 2011;32(6):1138-1142.
39. Raz E, Bester M, Sigmund EE, et al. A better characterization of spinal cord damage in multiple sclerosis: a diffusional kurtosis imaging study. AJNR Am J Neuroradiol. 2013;34(9):1846-1852.
40. Kearney H, Schneider T, Yiannakas MC, et al. Spinal cord grey matter abnormalities are associated with secondary progression and physical disability in multiple sclerosis. J Neurol Neurosurg Psychiatry. doi:10.1136/jnnp-2014-308241.
41. Gabilondo I, Martínez-Lapiscina EH, Martínez-Heras E, et al. Trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis. Ann Neurol. 2014;75(1):98-107.
42. Balk LJ, Steenwijk MD, Tewarie P, et al. Bidirectional trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2015;86(4):419-424.
43. Calabrese M, Magliozzi R, Ciccarelli O, Geurts JJ, Reynolds R, Martin R. Exploring the origins of grey matter damage in multiple sclerosis. Nat Rev Neurosci. 2015;16(3):147-158.
44. Gilmore CP, Bö L, Owens T, Lowe J, Esiri MM, Evangelou N. Spinal cord gray matter demyelination in multiple sclerosis-a novel pattern of residual plaque morphology. Brain Pathol. 2006;16(3):202-208.
45. Magliozzi R, Howell OW, Reeves C, et al. A gradient of neuronal loss and meningeal inflammation in multiple sclerosis. Ann Neurol. 2010;68(4):477-493.
46. Wegner C, Esiri MM, Chance SA, Palace J, Matthews PM. Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology. 2006;67 (6):960-967.